Share on: 
Website: ContraFect

ContraFect is a clinical stage biotechnology company focused on discovering and developing therapeutic proteins and antibodies for life-threatening, drug-resistant infectious diseases, particularly those treated in hospital settings.  ContraFect's initial product candidates include new agents to treat antibiotic-resistant infections such as MRSA (methicillin resistant Staph aureus) and influenza.  

The company is developing products using phage lysins and monoclonal antibodies.

Career Page(s): 
Yonkers NY
United States